Dr. Agha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5115 Centre Ave
3rd Floor
Pittsburgh, PA 15232Phone+1 412-864-6648Fax+1 412-864-6666
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 1989 - 1992
- Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 1986 - 1989
- University of Aleppo Faculty of MedicineClass of 1983
Certifications & Licensure
- PA State Medical License 1987 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Start of enrollment: 2004 Jan 01
- Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) Start of enrollment: 2004 Aug 01
- Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia Start of enrollment: 2008 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 61 citationsSuboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking EraMounzer Agha, Maggie Blake, Charles Chilleo, Alan Wells, Ghady Haidar
Open Forum Infectious Diseases. 2021-06-30 - 77 citationsSuboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patientsMounzer Agha, Maggie Blake, Charles Chilleo, Alan Wells, Ghady Haidar
Medrxiv. 2021-04-07 - 679 citationsCiltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CART...Jesus G. Berdeja, Deepu Madduri, Saad Z. Usmani, Andrzej Jakubowiak, Mounzer Agha
Lancet. 2021-07-24
Authored Content
- Updated Results from CARTITUDE-1: Phase 1b/2Study of Ciltacabtagene Autoleucel, a B-cell Maturation Antigen–Directed Chimeric Antigen Receptor T Cell Therapy, in Patients with Relapsed/Refractory Multiple MyelomaDecember 2021
Press Mentions
- Who Qualifies for a Coronavirus Booster Shot? Why It’s Still UnclearAugust 13th, 2021
- Protecting the Immune-Compromised Keeps Everyone SafeAugust 5th, 2021
- The Complex Situation for Immunocompromised People and COVID-19 VaccinesJune 16th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: